CN1918126B - Ionic UV-A sunscreens and compositions containing them - Google Patents

Ionic UV-A sunscreens and compositions containing them Download PDF

Info

Publication number
CN1918126B
CN1918126B CN200580004920XA CN200580004920A CN1918126B CN 1918126 B CN1918126 B CN 1918126B CN 200580004920X A CN200580004920X A CN 200580004920XA CN 200580004920 A CN200580004920 A CN 200580004920A CN 1918126 B CN1918126 B CN 1918126B
Authority
CN
China
Prior art keywords
group
acid
alkyl
described compound
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200580004920XA
Other languages
Chinese (zh)
Other versions
CN1918126A (en
Inventor
凯特加·伯格-舒尔茨
乌尔里克·休伯
丹尼尔·斯普伦格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of CN1918126A publication Critical patent/CN1918126A/en
Application granted granted Critical
Publication of CN1918126B publication Critical patent/CN1918126B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)

Abstract

The present invention relates to novel 1,4-dihydropyridine derivatives, to novel cosmetic or dermatological sunscreen compositions containing these derivatives and the use of these derivatives for photoprotecting human skin and/or hair against UV radiation, in particular solar radiation.

Description

Ionic UV-A sun-screening agent and contain the composition of this sun-screening agent
The present invention relates to new 1; new sun-screening agent (sunscreen) composition that 4-dihydrogen pyridine derivative, the cosmetic that contains this derivative or dermatology are used; and this analog derivative is to people's skin and/or hair ultraviolet radiation resisting, and especially the application of photoirradiation protection is carried out in the anti-sun light irradiation.
In accepting the crowd that harmful amount of sunlight increases, the requirement of preventing coating protection agent is continued to increase.Sun exposure can cause that skin changes repeatedly, i.e. photoaging skin.The visible clinical change is different from the clinical change of the normal aging skin at the anti-solar exposure position of human body in photoaging skin.In the damage result of skin big area Exposure to Sunlight, corrugate, before the elastosis, pigment variation, canceration and the carninomatosis skin injury more and more.
Past, developed many sun-screening agent chemical, can to UV-A (320~400nm) and/or UV-B (290~320nm) wavelength and even more short wavelength's (UV-C) deleterious effect protect.These chemical or separately or mutually combination join be widely known by the people and widely used cosmetic or pharmaceutical preparation in.
Particularly UV-A irradiation can cause quick, direct faint cutaneous pigmentation.UV-A ray transdermal deep layer, and can quicken ageing processes of skin there.Irradiation than shortwave UV-A II promotes sunburn to form.The irradiation of UV-A II can also and then cause phototonus (phototonic) or photo sensitive reaction.Between UV-A irradiation and the increasing skin carcinoma danger relation is arranged.
Although a large amount of safe and effective UV-B absorption agents are arranged, be suitable for protecting people's the UV-A absorption agent of skin rather limited for number.Well behaved UV-A absorption agent should have good light stability, toxicology and dermatology acceptability, remarkable thermostability, the splendid solubility in the makeup solvent, the solubility in oil or water particularly, with stability in 4~9 scopes of the consistency of base material of cosmetics, pH value, add processability in the make-up preparation, with the consistency of other make-up preparation compositions and wrapping material, do not stain textiles, the flavor of smelling of should be colourless, having natural or smelling good, and should not have viscosity, and has low volatility.Especially to the goods that are used for hair such as hairspray, shampoo, hair care product etc., must meet strict requirement, and the UV absorption agent must stick on the hair, so that sufficient protection to be provided.
Oil soluble sun-screening agent in UV-A scope tool sorption for instance, is disclosed among the WO03/068183.
Satisfying the available UV-A absorption agent kind number of at least some requirements in the above-mentioned various requirement, this is just few, and is water-soluble or be applicable to that the UV-A absorption agent kind number of hair is even still less.The advantage of water-soluble UV-A sun-screening agent is to be introduced into the aqueous phase of oil-in-water-type or water-in-oil emulsion.Because in these emulsions, water is more than oil phase usually, the sun-screening agent that therefore can add water is more than the sun-screening agent that can add oil phase, thereby obtains the composition of higher SPF (sun protection factor).And, water-soluble UV-A opalizer can with the known oil-soluble UV-A opalizer combination in the oil phase of two phase emulsion, this also can cause SPF (sun protection factor) to increase.
For instance, disclose some water-soluble UV-A sun-screening agents among the EP-A 669 323, both disclosed water-soluble sun-screening agent in this patent application, also disclose the oil soluble sun-screening agent.Yet disclosed water-soluble UV-A sun-screening agent in this document, compound phenyl bisbenzimidazole tetrasulfonic acid disodium for example, its absorption peak be at the 335nm place, and extinction value E only is 745, and this value is lower.It is preferred that absorption peak is situated between between 350~370nm.In addition, also preferably use water-soluble and/or advantageously stick on the hair, that extinction value E is high, as to improve sun-screening agent effect UV-A sun-screening agent.The E value is preferably greater than 1000 greater than 900, and for example 1000~1200th, very favorable.
Also disclose some UV-A sun-screening agents among the DE 33 24 735, and more disclosed sun-screening agents also are water miscible in this document.The example of this water-soluble UV-A sun-screening agent is Terephthalidene Dicamphor Sulfonic Acid (terephthalylidene dicamphor sulfonic acid), yet the optical extinction coefficient E of this compound only is 866, and absorption peak is at the 345nm place.
The current needs that still exist more UV-A sun-screening agents, this sun-screening agent be water miscible and/or can stick on the hair, not only meet top pointed sun-screening agent requirement, and but on quite high wavelength, also have absorption peak, preferably between 350~370nm, and has a fabulous E value, preferred 900 or higher, more preferably 1000 or higher.
Compound shown in the general formula I has been realized this purpose
Figure S05804920X20060818D000021
In the formula,
R 1And R 2Be identical or different suction electric charge subbase group, perhaps R 1And R 2In one be hydrogen, and another person is for inhaling electric charge subbase group,
R 3, R 4, R 5And R 6Be independently selected from hydrogen atom, C 1-C 10Alkyl, C 2-C 10Alkenyl, C 2-C 10Alkynyl, C 3-C 10Cycloalkyl or, C 6-C 10Aryl, above-mentioned each group is replaced by 1 to 3 substituting group by unsubstituted or optional, and described substituting group is selected from C 1-C 6Alkyl, halogen, hydroxyl and C 1-C 6Alkoxyl group, perhaps R 3And R 5And/or R 4And R 6Constitute 5 yuan or 6 yuan of rings together with the carbon atom that it connected, these 5 yuan or 6 yuan ring is optional to be replaced by 1 to 4 substituting group, and described substituting group is selected from C 1-C 6Alkyl, C 3-C 6Cycloalkyl, C 1-C 6Alkoxyl group, hydroxyl or halogen,
X is for containing 1 to 20 carbon atom and optional 1 to 10 heteroatoms, and contains the alkyl of the group of at least one lotus positive electricity or bear electricity, and
Y is counter ion.
As used in the present specification, term " electron-withdrawing group " is meant that those contain the group of multikey, for example is preferably cyano group or nitrilo (CN group), perhaps-and COOR 8,-COR 8Or-CONR 8 2Group, each R in the formula 8Be hydrogen, C independently of one another 1-C 21Alkyl (preferred C 1-C 6Alkyl), C 2-C 21Alkenyl (preferred C 2-C 6Alkenyl), C 2-C 21Alkynyl (preferred C 2-C 6Alkynyl), C 3-C 21Cycloalkyl (preferred C 3-C 8Cycloalkyl) or C 6-C 10Aryl (preferred phenyl), each group in these groups or the preferred group are not substituted or are optional by 1~3 substituting group replacement, and substituting group is selected from C 1-C 6Alkyl, halogen, hydroxyl and C 1-C 6Alkoxyl group.Preferably, radicals R 1And R 2In at least one be cyano group, most preferably, radicals R 1And R 2Be cyano group (CN group).Also preferably, a group is a cyano group, and another group is-COOR 8
R 3, R 4, R 5And R 6Be independently selected from hydrogen atom, C 1-C 10Alkyl, C 2-C 10Alkenyl, C 2-C 10Alkynyl, C 3-C 10Cycloalkyl and C 6-C 10Aryl.Each group in these groups can be unsubstituted, is perhaps replaced by 1 to 3 substituting group, and described substituting group is selected from C 1-C 6Alkyl, halogen, hydroxyl and C 1-C 6Alkoxyl group.As another kind of selection scheme, also can make R 3And R 5And/or R 4And R 6Constitute 5 yuan or 6 yuan of rings together with the carbon atom that it connected, these 5 yuan or 6 yuan ring is optional to be replaced by 1 to 4 substituting group, and described substituting group is selected from C 1-C 6Alkyl, C 3-C 6Cycloalkyl, C 1-C 6Alkoxyl group, hydroxyl or halogen.Preferably, R 3, R 4, R 5And R 6Be independently selected from hydrogen atom, C 1-C 6Alkyl, C 2-C 6Alkenyl, C 5-C 8Cycloalkyl and phenyl, each group in these groups is optional to be replaced by 1~3 substituting group, more preferably, is replaced by a substituting group as defined above.Also preferably, R 3, R 4, R 5And R 6Be independently selected from hydrogen atom and unsubstituted C 1-C 6Alkyl, C 2-C 6Alkenyl, C 5-C 8Cycloalkyl and phenyl.If R 3And R 5And/or R 4And R 6Constitute 5 yuan or 6 yuan of rings together with the carbon atom that it connected, then be preferably 6 yuan of rings, and should preferably not replace or be replaced by ring by a substituting group as defined above.
Most preferably, R 3, R 4, R 5And R 6In at least one, more preferably R 3, R 4, R 5And R 6In two be hydrogen atom, and R 3, R 4, R 5And R 6Other groups in the group are C 1-C 6Alkyl or C 2-C 6Alkenyl.R most preferably 3And R 4Be hydrogen atom, and R 5And R 6Be C 1-C 6Alkyl or C 2-C 6Alkenyl, more preferably C 1-C 3Alkyl.
Alkyl can be side chain or straight chain.C 1-C 10The preferred example of alkyl is methyl, ethyl, propyl group, sec.-propyl, butyl, sec-butyl, isobutyl-, amyl group, neo-pentyl, hexyl, 2-ethylhexyl and octyl group.
C 3-C 10The preferred example of cycloalkyl is cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, suberyl and ring octyl group.
C 2-C 6The preferred example of alkenyl is vinyl and positive propenyl.
C 6-C 10The preferred example of aryl is phenyl and naphthyl.
X is for containing 1 to 20 carbon atom, preferred 1 to 10 carbon atom, more preferably 1 to 6 carbon atom and optional 1 to 10 heteroatoms, preferred 1 to 6 heteroatomic straight chain, side chain, ring-type or aromatic hydrocarbyl of containing.According to this specification sheets, contain heteroatomic alkyl and also can contain functional group such as hydroxyl.Heteroatoms is preferably selected from O, N, S and P atom.For the present invention, importantly, radicals X comprises at least one group, preferably includes the group of 1,2 or 3 lotus positive electricity or bear electricity.X is preferably alkyl, aryl, alkaryl, the alkyl-cycloalkyl that contains 1 to 20 carbon atom and optional 1 to 10 heteroatoms and comprise at least one lotus positive electricity or bear electric group.Term " alkaryl " or " alkyl-cycloalkyl " mean aryl or the cycloalkyl that contains one or more alkyl substituents.Because radicals X comprises the group of at least one lotus positive electricity or bear electricity, so it contains the heteroatoms of at least one lotus positive electricity or bear electricity usually.Preferably, the X group contains 1 to 6 heteroatoms, and described heteroatoms is preferably selected from nitrogen, oxygen, sulphur or phosphorus atom.If radicals X lotus positive electricity, the then preferred nitrogen-atoms that contains a lotus positive electricity at least, thereby the group of this lotus positive electricity is a quaternary ammonium group.This compound of quaternary ammonium ion that comprises is particularly preferred for hair.If radicals X contains the bear electric group, then this bear electric group is preferably acidic group, for example phosphate or sulfate or carboxylic acid residues.
The X group also can contain 1 to 4 unsaturated C-C, preferred two keys.Each carbon atom can be chosen wantonly by functional group and replace in the X group, specifically, by hydroxyl or amino the replacement, is preferably replaced by hydroxyl.Define in the X group of replacement no more than 3 of substituted carbonatoms above preferred, more preferably no more than 2.Certainly, if the carbon atom in the X group is replaced by amino, may be unsaturated link(age) also between carbon atom and the nitrogen-atoms then, be preferably two keys.Also possible is that X group and Y group constitute the zwitter-ion structure jointly.
If the group bear electricity of lotus positive electricity or bear electricity in the X group, negative charge of the preferred lotus of X group then, and most preferably be acidic group for example-O-SO 3 -,-COO -,-O-PO 3H -,-O-PO 3 2-,-SO 3 -,-PO 3H -Or-PO 3 2-Most preferably be-O-SO 3 -,-SO 3 -With-O-PO 3H -The X group that comprises at least one bear electric group, its exemplary is for choosing wantonly by the alkylidene group of cycloalkyl or aryl replacement, by cycloalkyl or aryl alkylidene group at interval and the alkylidene group that contains the top acidic group that defines.In a kind of preferred embodiment, this alkylidene group is by 1 to 3 heteroatoms interval, and described heteroatoms is preferably selected from oxygen and nitrogen-atoms interval, and described heteroatoms is preferably selected from oxygen, nitrogen-atoms and nitrogen-atoms.This alkylidene group preferably contains 1 to 10 carbon atom, more preferably contains 1 to 6 carbon atom.If this alkylidene group by nitrogen-atoms at interval, then this nitrogen-atoms also has radicals R as defined above 8
The preferred embodiment of the X group of the single negative charge of lotus is a group
-(C (R 9 2)) n-(V) m-(C (R 9 2)) o-(U) p-(C (R 9 2)) q-W, each R in the formula 9Be hydroxyl independently, R perhaps as defined above 8Group also is preferably hydrogen atom, hydroxyl or C 1-C 3Alkyl, V and U are heteroatoms independently, and (this nitrogen-atoms also has R as defined above to be preferably Sauerstoffatom or nitrogen-atoms 8Group), Sauerstoffatom more preferably, n is 0~6 integer (being preferably 1~6), m is 0 or 1, o is 0~6 integer (being preferably 1~6), and p is 0 or 1, and q is 0~6 integer (being preferably 1~6), and W is the group of bear electricity, is preferably acidic group as defined above, most preferably is-O-PO 3H -,-SO 3 -Perhaps-O-SO 3 -, precondition is, the total number of carbon atoms is 20 or still less, be preferably 10 or still less, most preferably be 1~6, precondition is that the heteroatoms sum comprises that the heteroatoms among the W of functional group is 1~10 in the X group simultaneously, its precondition is, if subscript m and p are 1, then subscript o is not 0.Preferred no more than 4 R 9Group, more preferably no more than 2 R 9Group is different from hydrogen, most preferably all R 9Group is hydrogen.
Another preferred embodiment of the X group of the single negative charge of lotus is a group
-Ar-W,
In the formula, Ar is an aromatic group, preferred C 6-C 10Aryl such as phenylene or naphthylidene, perhaps heterocyclic group is preferably 4~10 yuan of rings, wherein one or more, preferred 1 or 2 annular atoms is a heteroatoms, is preferably N, O or S.This heterocyclic group can be saturated or undersaturated group, and heteroaromatic group, and for example pyridylidene also is included in wherein.W is person as defined above.
Further preferably, at least one group of lotus positive electricity or negative electricity is the group of a positive charge of lotus in the X group.Most preferably this group of a positive charge of lotus is a quaternary ammonium group.In the case, the X group is preferably the group shown in the following formula
Figure S05804920X20060818D000061
In the formula, each R 10Be hydrogen or R independently 11, and each R 11Independently with top defined R 8, be preferably hydrogen, C 1-C 10Alkyl, being preferably can be by 1 to 4 heteroatoms C at interval 1-C 6Alkyl is preferably by 1 or 2 heteroatoms C at interval 1-C 6Alkyl is preferably by 1 or 2 Sauerstoffatom C at interval 1-C 6Alkyl, and this C 1-C 10Alkyl can be selected from hydroxyl, amino and C by 1 to 3 1-C 6Alkyl (preferred C 1-C 3Alkyl) substituting group replaces, subscript r is 1~10 integer, be preferably 1~6 integer, precondition is, the total number of carbon atoms is 20 or less than 20 in the X group, and is preferred 1~10, and comprises that the heteroatoms sum of all heteroatomss in nitrogen-atoms and the functional group is preferably 1~10, preferred 1~6, more preferably 1~4.Comprise at least one as defined above the compound of quaternary ammonium ion be specially adapted to hair, for example hair care product, shampoo, hair jelly or the like.In one embodiment of the invention, R 11Group can contain a negative charge, thereby comprises Y group, for example a R 11Group can be by bear electricity functional group as-SO 3 -Or the alkyl of similar group replacement.
In a preferred embodiment, the XY group is the zwitter-ion of hold concurrently lotus positive electricity and negative electricity, and its carbonatoms, heteroatoms number and functional group's number are as defined above.
The definite structure of X group and irrelevant is as long as its lotus has at least one can make molecule water-soluble and/or positive charge or negative charge with the cohesive force of hair be provided.Preferably, X contains one, two or three positive charges or negative charge.
Y group be should balance X group electric charge counter ion.The definite chemical property of counter ion Y is not critical to the present invention, as long as counter ion Y does not play detrimentally affect to the advantageous characteristic of UV-A absorption agent, and especially as long as Y can give acceptance on dermatology and aspect the makeup.If X group bear, then Y group is preferably quaternary ammonium ion, alkalimetal ion or alkaline-earth metal ions, more preferably sodium ion, potassium ion, calcium ion or magnesium ion, but Y group also can be the organic group of lotus positive electricity, for instance, ammonium ion such as triethanol ammonium ion, amino methyl propyl alcohol ion or trometamol (tromethamine) ion.If Y group institute lotus positive electricity is more than X group institute bear electricity, then Y group also contains the counter ion of the unnecessary electric charge of energy balance, perhaps comes above X group of balance with a Y group.For instance, Y group can be Or M S+(A-) S-1, M wherein S+Be lotus carbonium, A -Be the ion such as the halogen atom of the single negative charge of lotus, s is 1~3, preferred 1 or 2, more preferably 1.
If X group lotus positive electricity, then Y bear electricity, and Y group are preferably halogen atom such as chlorine atom, bromine atoms or iodine atom.If Y group institute bear electricity is more than X group institute lotus positive electricity, then Y group also contains the counter ion of the unnecessary electric charge of energy balance, perhaps comes above X group of balance with a Y group.For instance, Y group can be (M S-) or M S-(A +) S-1, M wherein S-Be bear electron ion, A +Be the ion such as the alkalimetal ion of the single positive charge of lotus, s is 1~3, preferred 1 or 2, more preferably 1.
If then can there be above Y counter ion in above electric charge of X group band, the perhaps Y group band electric charge that contends with more than.Importantly, select Y group to make the neutral on the whole of molecule shown in the formula I.
X and Y are combined, just as at-(CH with chemical mode 2) rN +(R 11) 2-(CH 2) t-SO 3 -Like that, wherein r is the same defines in the part, and t is 1~10 integer, is preferably 1~5 integer, and for example 2.In each embodiment of this situation, X group and Y group constitute the zwitter-ion structure jointly.
The preferred R that selects 1To R 6, X and Y make the solubleness of molecule be at least 10g/l, preferably is at least 50g/l, more preferably is at least 100g/l.If the solubleness of compound shown in the formula I is enough not big, then can change substitute mode, for example can reduce R 3To R 6Carbonatoms in the group can be removed aryl or the group of naphthene base that solubleness is reduced from some or all groups, and can contain the hydrophilic substituent such as hydroxyl.
To the compound of the very big cohesive force of hair tool as top definition general formula-C (R 10 2) r-N +(R 11) 3Quaternary ammonium ion, its solubleness may be lower.
The preferred compound of the present invention is
Figure S05804920X20060818D000072
Figure S05804920X20060818D000073
Figure S05804920X20060818D000075
Figure S05804920X20060818D000081
Figure S05804920X20060818D000084
Figure S05804920X20060818D000087
Figure S05804920X20060818D000088
Figure S05804920X20060818D000089
Figure S05804920X20060818D0000810
Figure S05804920X20060818D0000811
Figure S05804920X20060818D000091
Figure S05804920X20060818D000093
Figure S05804920X20060818D000094
Figure S05804920X20060818D000095
Figure S05804920X20060818D000097
Figure S05804920X20060818D000098
Figure S05804920X20060818D000099
Figure S05804920X20060818D0000911
Figure S05804920X20060818D000101
Figure S05804920X20060818D000102
Figure S05804920X20060818D000103
Figure S05804920X20060818D000104
Figure S05804920X20060818D000105
Figure S05804920X20060818D000107
Figure S05804920X20060818D000109
Figure S05804920X20060818D0001011
Figure S05804920X20060818D0001012
Figure S05804920X20060818D000111
And the combination or the exchange of different structure unit (structure element).
Compound
Figure S05804920X20060818D000112
With
Figure S05804920X20060818D000113
Water-soluble may be little, but they are particularly preferred for hair nursing.
Compound shown in the formula I can prepare with known method itself.Have certain methods to be disclosed among the embodiment, these those skilled in the art can adopt these methods to come other compounds shown in the preparation formula I easily.
Wherein X ' is the front body structure of XY.
-O-PO 3 2-The phosphate radical residue of type can be for example by corresponding alcohol functional group as using POCl 3With alkali triethylamine (for example referring to M.-Z.Liu et al., Carbohy dr.Res.330 (3), 413-420 (2001)) for example, with P 2O 5And H 3PO 4(for example referring to K.Buss et al., J.Med.Chem.44 (19), 3166-3174 (2001)) or prepare by enzymatic means.
-O-SO 3 -The sulfate radical residue of type can be for example by corresponding alcohol functional group as using SO 3* pyridine (for example referring to W.J.Sanders et al., Tetrahedron 53 (48), 16391-16422 (1997)) and SO 3* NEt 3(for example referring to B.Ferla et al., Tetrahedron 55 (32), 9867-9880 (1999)), chlorsulfonic acid (for example referring to G.Dekany et al., J.Carbohy dr.Chem.16 (1), 11-24 (1997)) or H 2SO 4(for example referring to S.P.Gaur et al., Indian J.Chem.Sect.B21 (1), 46-51 (1982)) preparation.
Preferred compounds more of the present invention and general preparation method thereof are as follows:
Method a)
Figure S05804920X20060818D000121
Method b)
Be similar to:
Method c)
Be similar to:
Figure S05804920X20060818D000125
Method d)
Figure S05804920X20060818D000131
Be similar to:
Figure S05804920X20060818D000132
Method e)
Figure S05804920X20060818D000133
The same
Figure S05804920X20060818D000134
Method f)
Figure S05804920X20060818D000135
Method g)
Method h)
Figure S05804920X20060818D000141
Method i)
Method j)
Figure S05804920X20060818D000143
Be similar to embodiment 2:
Figure S05804920X20060818D000144
Be similar to embodiment 1:
Figure S05804920X20060818D000146
Compound is especially preferred shown in the following general formula (I):
R 1And R 2Group is cyano group, radicals R 3, R 4, R 5And R 6Be selected from hydrogen atom and C independently of one another 1-C 6Alkyl, Y are the counter ion of balance X group electric charge, decide according to the electric charge of X, are preferably alkalimetal ion or halogen ion, and
A) X is a group
-(C(R 9 2)) n-(V) m-(C(R 9 2)) o-(U) p-(C(R 9 2)) q-W,
Each R in the formula 9Be hydrogen, hydroxyl or C independently of one another 1-C 3Alkyl, V and U are Sauerstoffatom, and n is 1~3 integer, and m is 0 or 1, and p is 0 or 1, and wherein at least one is 1 among m and the p, and o is 1~3 integer, and q is 1~3 integer, and W is-O-PO 3H -Group or-O-SO 3 -Group, perhaps
B) X is a group
Figure S05804920X20060818D000151
In the formula, each R 10Group is independently selected from hydrogen atom, hydroxyl and C 1-C 3Alkyl, and R 11Group is independently selected from hydrogen atom and optional by 1 to 2 Sauerstoffatom interval and the optional C that is replaced by 1 to 3 hydroxyl 1-C 6Alkyl, and r is 1~6 integer, perhaps
C) X is a group
-(C(R 9 2)) n-(V) m-(C(R 9 2)) o-(U) p-(C(R 9 2)) q-W,
R in the formula 9Be respectively hydrogen or methyl separately, V and U are Sauerstoffatom, and n is 1~3 integer, and m is 0 or 1, and p is 0 or 1, and wherein at least one is 1 among m and the p, and o is 1~3 integer, and q is 1~3 integer, and W is-O-PO 3The H-group or-O-SO 3 -Group, perhaps
B) X is a group
Figure S05804920X20060818D000152
In the formula, R 10Group is selected from hydrogen atom, hydroxyl and C respectively 1-C 3Alkyl, and R 11Group is selected from hydrogen atom and optional by 1 to 2 Sauerstoffatom interval and the optional C that is replaced by 1 to 3 hydroxyl respectively 1-C 6Alkyl, and r is 1~3 integer, perhaps
E) X is a group
-(C(R 9 2)) n-(V) m-(C(R 9 2)) o-W,
In the formula, R 9Be hydrogen or methyl independently of one another, V is a Sauerstoffatom, and n is 1~3 integer, and m is 1, and o is 1~3 integer, and W is group-O-PO 3H -Or-O-SO 3 -, perhaps
F) X is a group shown in the following formula
Figure S05804920X20060818D000161
In the formula, radicals R 10Be selected from hydrogen atom and C independently of one another 1-C 3Alkyl, radicals R 11Be selected from optional independently of one another by 1 or 2 heteroatoms interval and the optional C that is replaced by 1 to 3 hydroxyl 1-C 6Alkyl, and r is 1~3 integer, perhaps
G) X is a group shown in the following formula
-(C(R 9 2)) n-W,
In the formula, each R 9Be hydrogen, hydroxyl or C independently of one another 1-C 3Alkyl, n are 1~6 integer, and W is group-O-PO 3H -Or-O-SO 3 -, perhaps
H) X is a group shown in the following formula
Figure S05804920X20060818D000162
In the formula, R 10Be selected from hydrogen atom, hydroxyl and C independently of one another 1-C 3Alkyl, two R 11Group is C 1-C 3Alkyl, a R 11Group is interrupted by 1 or 2 Sauerstoffatom and the optional C that is replaced by 1 to 3 hydroxyl for optional 1-C 6Alkyl, and r is 1~3 integer, perhaps R 11Group and nitrogen-atoms constitute pyridyl jointly, and this pyridyl is not substituted, perhaps by 1 to 5, preferably by the substituent R that defines above 1 to 3 8Replace.
I) above a) to h) in the group in each group of defining, one of them radicals R 9Or R 10For saturated or undersaturated, contain the nitrogenous alkyl of 5 carbon atoms and one or two nitrogen-atoms at the most.
The solubleness of The compounds of this invention that contains following groups is high especially, and compound is particularly preferred shown in the general formula (I):
Shown in group be not substituted, perhaps by 1 to 5, preferred 1 to 3 substituent R as defined above 8Replace.
The invention still further relates to the various compound compositions shown in the general formula (I) that is formulated in appropriate carrier or the base-material that contain.Representative is, the present composition is used for protecting the material to the ultraviolet irradiation sensitivity, and especially to the material of solar radiation sensitivity, described composition comprises compound shown at least a general formula (I) of effective illumination protective number.In a preferred embodiment of the invention, this composition is suitable for protecting skin and/or hair not to be subjected to the deleterious effect of ultraviolet irradiation.In the case, composition of the present invention is make-up composition or pharmaceutical composition, and it comprises that acceptable vehicle of local available, makeup or pharmacology or thinner make carrier.According to another embodiment of the invention, compound can add in the plasticity base-material shown in the general formula (I).Compound shown in the general formula (I) also can be used to make local stable with the photosensitive composition in the preparation, especially tinting material, for example FD﹠amp; C, D﹠amp; The C tinting material, turmeric yellow (curcumin), riboflavin (riboflavine), riboflavin (lactoflavine), Tartrazol yellow (tartrazine), quinoline Huang (chinolinyellow), cochineal (cochenille), azorubin (azorubine), amaranth, ponceau 4R, erythrosine (erythrosin), indigo-blue, chlorophyll (chlorophylle), CHLOROPHYLLINE, caramel, Medicinal Charcoal, carotenoid, bixin, norbixin (norbixin), aronotta (annatto), capsanthin (orlean), Capsanthin (capsanthin), Capsorubin (capsorubin), lycopin (lycopin), xenthophylls (xanthophylle), flavoxanthin (flavoxanthin), xenthophylls (lutein), cryptoxanthin (kryptoaxanthin), rubixanthin (rubixanthin), zeaxanthin diepoxide (violaxanthin), rhodoxanthin (rhodoxanthin), canthaxanthin (canthaxanthin), betanin (betanin), anthocyan (anthocyan), VITAMIN such as vitamin A, vitamin K1, vitamins C, perhaps other activeconstituentss.
The obtained the maximum absorption of compound is in the UV-A zone shown in the general formula (I).For the purpose of the preparation sun-screening agent; especially use and/or Toiletry preparation for the preparation dermatology; for the purpose of the skin care or sunscreen formulas goods in for example daily makeup, compound shown in the general formula (I) can be spiked in the auxiliary agent, for example be spiked into the base material of cosmetics that is used for these prescription goods routinely.Under occasion easily, also can add other UV-A or UV-B sun-screening agents commonly used, be preferably pigment.Uv filters meeting show synergistic is adopted in combination.The preparation of above-mentioned sun-screening agent, this field those of skill in the art all know.The concentration of uv filters can change in the scope of broadness.For instance, the amount of the optional extra wetting ability outside the compound and/or lipotropy UV-A or UV-B sun-screening agent shown in compound shown in the general formula (I) and the general formula (I) can be in 0.5~12% (weight) scope that is as the criterion in composition total weight.These extra sun-screening agents are favourable to be selected from following compounds, but are not limited to these compounds:
UV-B or wide spectrum sun-screening agent, also be obtained the maximum absorption at about material of 290 to 340nm, its example that is used in combination with The compounds of this invention that is considered for example is following organic compound and mineral compound:
---acrylate, for example Viosorb 930 (octocrylene, PARSOL
Figure S05804920X20060818D000181
340), 2-cyano-3,3-diphenyl ethyl acrylate etc.;
---camphor derivatives, for example 4 methyl benzylidene camphor (PARSOL
Figure S05804920X20060818D000182
5000), 3-benzylidene camphor, camphor benzalkonium methylsulfuric acid ester, polyacrylamide base methyl benzylidene camphor, sulfo group benzylidene camphor, sulphur methyl benzylidene camphor, Terephthalidene Dicamphor Sulfonic Acid (therephthalidene dicamphor sulfonic acid) etc.;---cinnamate derivates, for example octyl methoxycinnamate (PARSOL
Figure S05804920X20060818D000183
MCX), methoxy cinnamic acid ethoxyethyl group ester, diethanolamine methoxy cinnamate salt (diethanolaminemethoxycinnamate, PARSOL
Figure S05804920X20060818D000184
Hydro), the methoxy cinnamic acid isopentyl ester, with the cinnamic acid derivative of siloxanes bonding;
---para-amino benzoic acid derivative, for example para-amino benzoic acid, ESCAROL 507 2-(ethyl hexyl) ester, N-oxypropylene groupization (N-oxypropylenated) parathesin, para-amino benzoic acid glyceryl ester.
---benzophenone, for example benzophenone-3, benzophenone-4,2,2 ', 4,4 '-tetrahydroxy-benzophenone, 2,2 '-dihydroxyl-4,4 '-dimethoxy benzophenone etc.;
--the ester of-benzylidene malonic acid, for example 4-methoxyl group benzylidene malonic acid two (2-ethylhexyl) ester;
--the ester of-2-(4-phenetidine methylene) propanedioic acid, 2-(the 4-phenetidine methylene) diethyl malonate of for example being put down in writing among the EP 0,895 776.
The organosilicone compounds of phenylmalonate ester---contain (benzmalonate) base is as EP0358584 B1, EP 0538431 B1 and EP 0709080 A1 record person;
---drometrizole trisiloxanes (drometrizole trisiloxane) (Mexoryl XL);
---pigment such as microgranular TiO 2Deng." microgranular " means the about 5nm of granularity to about 200nm, and especially about 15nm is to the particle of about 100nm.TiO 2Particle also can be coated with the metal oxide such as aluminum oxide or zirconium white, perhaps is coated with organic coating such as polyvalent alcohol, polymethyl siloxane (methicone), aluminum stearate, alkyl silane.These coating are well-known in this field.
---imdazole derivatives such as 2-Phenylbenzimidazole sulfonic acid and salt (PARSOL thereof
Figure S05804920X20060818D000185
HS).The example of 2-Phenylbenzimidazole sulfonate for example is an alkali metal salt such as sodium salt or sylvite, ammonium salt, alkylbenzyldimethylasaltsum saltsum, primary amine salt, secondary amine salt and tertiary ammonium salt such as monoethanolamine salt, diethanolamine salt etc.
---salicylic acid ester derivative, for example Whitfield's ointment isopropyl benzyl ester, benzyl salicylate, butyl salicylate, octyl salicylate (NEO HELIOPAN OS), the different monooctyl ester of Whitfield's ointment or Uniderm Homsal (homosalate, HELIOPAN) etc.
---pyrrolotriazine derivatives, for example UVINUL T-150 (UVINULT-150), dioctyl amide-based small triazone (UVASORB HEB), two guoethol methoxyphenyl triazine (Tinosorb S) etc.
Wide spectrum or UV A sun-screening agent also are obtained the maximum absorption about 320 to 400nm material, and its example that is used in combination with The compounds of this invention that is considered for example is following organic compound and mineral compound:
---dibenzoylmethane derivative for example, the 4-tertiary butyl-4 '-methoxy dibenzoyl methane (PARSOL 1789), dimethoxy phenyl phenacyl ketone, isopropyl diphenyl formyl radical methane etc.;
---benzotriazole derivatives, for example 2,2 '-methylene radical-two-(6-(2H-benzotriazole-2-yl)-4-(1,1,3, the 3-tetramethyl butyl)-phenol (TINOSORB M) etc.;
---phenylene-1,4-is two-benzoglyoxaline sulfonic acid or its salt, and for example 2,2-(1, the 4-phenylene) is two-(1H-benzoglyoxaline-4,6-disulfonic acid) (Neoheliopan AP);
The dihydroxy benaophenonel that---amino replaces, 2-(4-diethylamino-2-hydroxyl-benzoyl)-hexyl-benzoate for example is as the person of narrating among the EP 1046391;
---pigment such as microgranular ZnO or TiO 2Deng." microgranular " means the about 5nm of granularity to about 200nm, and especially about 15nm is to the particle of about 100nm.This particle also can coat other metal oxides such as aluminum oxide or zirconium white, perhaps coats organic coating such as polyvalent alcohol, polymethyl siloxane (methicone), aluminum stearate, alkyl silane.These coating are well-known in this field.
Because the light stability of phenyl phenacyl ketone derivative is limited, thus available it desirably make the UV-A sun-screening agent Photostabilised.Therefore, " commonly used UV-A sun-screening agent " also means the phenyl phenacyl ketone derivative, for example with the PARSOL of following material stabilization
Figure S05804920X20060818D000192
1789:
---3, the 3-diphenylacrylate is as the person of narrating among EP 0514491 B1 and EP 0780119 A1;
---benzylidene camphor derivative, as US 5,605, the person of narrating in 680;
---contain the phenylmalonic acid ester group organo-siloxane, as the person of narrating among EP 0358584 B1, EP0538431 B1 and EP 0709080 A1.
The present composition also contains habitual makeup adjuvant and additive; sanitas/antioxidant for example; fatty substance/oil; water; organic solvent; silicone; thickening material; tenderizer; emulsifying agent; auxiliary sun-screening agent; defoamer; wetting Agent for Printing Inks; spices; tensio-active agent; filler; sequestering agent; anionic polymer; cation type polymer; non-ionic polyalcohol or amphiphilic polymers or its mixture; propelling agent; souring agent or basifier; dyestuff; tinting material; pigment or nano-level pigment; especially those are suitable for covering the pigment that uv-radiation produces the additional light protective effect by physics mode; perhaps any other allocates the composition of makeup usually into, particularly is used for making the composition of shading/sunscreen composition.According to the product that will make, the auxiliary agent that those skilled in the art just can select to make up easily and dermatology is used and the expense of additive will be given among the application's the embodiment and illustrating, but be not limited to this.
Generally speaking, preferably add the antioxidant/sanitas of additional quantity.According to the present invention, allocate all known antioxidants of makeup usually into and all can use.Especially preferred is the antioxidant that is selected from following this class material: amino acid (for example; glycine; Histidine; tyrosine; tryptophane) and derivative; imidazoles (for example urocanic acid) and derivative; peptide (D for example; the L-carnosine; the D-carnosine; L-carnosine and derivative such as anserine); carotenoid; carotene (alpha-carotene; β-Hu Luobusu; Lyeopene) and derivative; chlorogenic acid and derivative; Thioctic Acid and derivative (for example Thioctic acid, dihydro-); aurothioglucose; propyl deracil and other mercaptan (Trx for example; gsh; halfcystine; Gelucystine; cystamine and glycosyl thereof; the N-ethanoyl; methyl; ethyl; propyl group; amyl group; butyl and lauryl; palmityl; oil base; y-18 carbon dialkylenes (y-linoleyl); cholesteryl and glyceryl ester) and salt; Tyox B; thio-2 acid distearyl ester; thio-2 acid and derivative (ester thereof; ether; peptide; lipoid; Nucleotide; nucleosides and salt) and sulphur oxygen imido (sulfoximine) compound of very low compatible dosage (for example pmol/kg to μ mol/kg) (S-(the amino 3-carboxylic of 3-propyl group)-S-butyl sulphur oxygen imido (buthionine sulfoximine) for example; homocysteine sulphur oxygen imido; S-(the amino 3-carboxylic of 3-propyl group)-S-butyl sulfone (buthionine sulfone); five-; six-; seven thionines (thionine) sulphur oxygen imido), also has (metal) sequestrant (alpha-hydroxy fatty acid for example in addition; palmitinic acid; phytinic acid; lactoferrin); beta-hydroxy acid (citric acid for example; lactic acid; oxysuccinic acid); humic acid; gallic acid; Galla Chinensis extract; bilirubin; uteroverdine; EDTA; EGTA and derivative thereof; unsaturated fatty acids and derivative thereof (gamma-linoleic acid for example; linolic acid; oleic acid); folic acid and derivative thereof; ubiquinone and ubiquinol (ubiquinol) and derivative thereof; vitamins C and derivative (for example Quicifal and xitix four different cetylates; Mg-ascorbic acid phosphoric acid esters (Mg-ascorbyl phosphate); the Na-ascorbic acid phosphoric acid esters; the xitix acetic ester)); vitamin-E and derivative (for example VITAMIN-E-acetic ester); the mixture of natural VE; vitamin A and derivative (VITAMIN-A-cetylate and VITAMIN-A-acetic ester) and coniferyl benzoic ether; rutinic acid and derivative; the alpha-glycosyl violaguercitrin; forulic acid; the furfurylidene sorbitol; carnosine; butylhydroxy toluene; butylated hydroxy anisole; trihydroxybutyrophenone (trihydroxybutyrophenone); urea and derivative thereof; seminose and derivative; zinc and derivative (ZnO for example; ZnSO 4), the suitable derivative (salt, ester, ether, sugar, Nucleotide, nucleoside, peptide and lipoid) of selenium and derivative (for example selenomethionine), stilbene and derivative (for example stilbene oxide compound (stilben oxide), trans-the stilbene oxide compound) and above-mentioned each activeconstituents.Be as the criterion in present composition gross weight, one or more sanitas/antioxidants can the extremely amount existence of about 10% (weight) of about 0.01% (weight).Preferably, one or more sanitas/antioxidants can the extremely amount existence of about 1% (weight) of about 0.1% (weight).
Generally, also contain surface active ingredient in the prescription such as emulsifying agent, solubilizing agent etc.Emulsifying agent can make two or more component uniform mixing that do not dissolve each other.And emulsifying agent also plays a part stable composition.Among the present invention, for forming O/W, W/O, O/W/O, W/O/W type emulsion/microemulsion, the emulsifying agent that may use comprises sorbitan oleate, sorbitan sesquioleate, sorbitan isostearate, the anhydrosorbitol trioleate, polyglyceryl (polyglyceryl)-3-diisopstearate, the poly glycidyl ester of oleic acid/Unimac 5680, polyglyceryl-6 six ricinoleate (hexaricinolate), polyglyceryl-4-oleic acid ester, polyglyceryl-4 oleic acid esters/PEG-8 propylene glycol cocounut oil ester (cocoate), oleoyl glycol amines (DEA), trolamine (TEA) myristinate, the TEA stearate, Magnesium Stearate, sodium stearate, potassium laurate, ricinoleic acid potassium, cocinic acid sodium (sodium cocoate), tallow acid (tallowate) sodium, castoric acid (castorate) potassium, sodium oleate, and composition thereof.Other suitable emulsifying agent is phosphoric acid ester and salt thereof, for example phosphoric acid n-Hexadecane ester (
Figure S05804920X20060818D000211
A), diethanolamine n-Hexadecane phosphoric acid ester ( ), the n-Hexadecane potassiumphosphate ( K), olein sodium phosphate (sodium glyceryl oleate phosphate), hydrogenated vegetable glyceryl ester phosphoric acid ester and composition thereof.In addition, one or more synthetic polymers can be used as emulsifying agent.For example, PVP eicosylene (eicosene) multipolymer, acrylate/C 10-30Alkyl acrylate cross-linked polymer (crosspolymer), acrylate/stearic alcohol ether (steareth)-20 alkylmethacrylate polymer, PEG-22/ dodecyl diol copolymer, PEG-45/ dodecyl diol copolymer, and composition thereof.Preferred solvent be the phosphoric acid cetyl ester (
Figure S05804920X20060818D000214
A), hexadecyl di(2-ethylhexyl)phosphate ethanolamine salt (
Figure S05804920X20060818D000215
), potassium cetyl phosphate ( K), PVP eicosylene multipolymer, acrylate/C 10-30-alkyl acrylate cross-linked polymer, PEG-20 sorbitan isostearate, sorbitan isostearate and composition thereof.Total amount of one or more emulsifying agents is about 0.01wt%~about 20wt% of present composition total amount.Preferably, use the emulsifying agent of about 0.1wt.%~about 10wt.%.
Lipoid can advantageously be selected from mutually:
Mineral oil and mineral wax;
Oil is capric acid (caprinic acid) or sad triglyceride level for example, preferred Viscotrol C;
Oil or wax and other natural or synthetic oil, in a preferred embodiment, lipid acid and alcohol, the ester of for example ester of Virahol, propylene glycol, glycerine, or Fatty Alcohol(C12-C14 and C12-C18) and carbonic acid or lipid acid;
Phenylformic acid alkyl ester; And/or
Silicone oil is dimethyl polysiloxane, diethyl polysiloxane, phenylbenzene polysiloxane, cyclomethicone (cyclomethicone) and composition thereof for example.
Can add exemplary fatty substance in the oil phase of emulsion of the present invention, microemulsion, oleogel, water dispersion or fatty dispersion and advantageously be selected from the alkyl carboxylic acid of saturated and/or unsaturated, straight chain or branching, 3~30 carbon atoms, with the ester of the alcohol of saturated and/or unsaturated, straight chain and/or branching, 3~30 carbon atoms, and the ester of the alcohol of aromatic carboxylic acid and saturated and/or unsaturated, straight chain or branching, 3-30 carbon atom.This kind ester can advantageously be selected from Wickenol 155, octyl group cocounut oil acid esters (cocoate), the Unimac 5680 monooctyl ester, Wickenol 142, the different pelargonate of 16/octadecyl (cetearyl), the tetradecanoic acid isopropyl esters, the palmitinic acid isopropyl esters, the stearic acid isopropyl esters, the oleic acid isopropyl esters, stearic acid just-butyl ester, lauric acid just-polyhexamethylene, oleic acid just-last of the ten Heavenly stems ester, the stearic acid isooctyl acrylate, the different nonyl ester of stearic acid, the different nonyl ester of different n-nonanoic acid, palmitinic acid 2-(ethyl hexyl) ester, lauric acid 2-(ethyl hexyl) ester, stearic acid 2-hexyl ester in the last of the ten Heavenly stems, palmitinic acid 2-octyl group dodecyl ester, the enanthic acid stearyl, oleic acid oil base ester, erucic acid oil base ester, oleic acid erucyl ester (erucyloleate), erucic acid erucyl ester, stearic acid tridecyl ester, the tridecyl trimellitate, with synthesizing of these esters, half-synthetic or natural mixture, for example Jojoba oil.
Other is applicable to that the lipid fraction of preparation of the present invention comprises polar oil (polar oils) for example Yelkin TTS (lecithin) and fatty acid triglycercide, be saturated and/or undersaturated, straight chain or branching, 8~24 carbon atoms, the triglyceride level of the carboxylic acid of preferred 12~18 carbon atoms, wherein fatty acid triglycercide is preferably selected from synthetic, semi-synthetic or natural oil (coconut oil glyceryl ester (cocoglyceride) for example, sweet oil, wunflower seed oil, soya-bean oil, peanut oil, rape seed oil, sweet almond oil, plam oil, Oleum Cocois, Viscotrol C, hydrogenated castor oil, wheat oil, wine stone oil, Queensland nut oil and other); Polar oil is for example mineral oil, Vaseline (vaseline) of straight chain and/or branched hydrocarbon and wax for example; Paraffin, squalane (squalane) and squalene (squalene), polyolefine, Parleam and isohexadecane, preferred polyolefine is a poly decene; Dialkyl ether, for example two decoyl ethers; The for example preferred cyclomethicone (cyclomethicone) (octamethylcyclotetrasiloxane) of straight chain or ring-type silicone oil, hexadecyl polydimethylsiloxane (cetyldimethicone), hexamethyl cyclotrisiloxane, polydimethylsiloxane, poly-(methylphenyl siloxane) and composition thereof.
Other lipid fraction that can advantageously add in the preparation of the present invention comprises Isoeicosane (isoeikosane), neopentyl glycol two heptanoates, propylene glycol dicaprylate/dicaprate, caprylic/capric/two glyceryl succinates, butyleneglycol octanoate/decylate, C 12-13-alkyl lactate ester, two C 12-13-alkyl tartrate, three Tegin ISOs, Dipentaerythritol six octanoates/six decylates, Propylene glycol monoisostearate, tricaprylin, Isosorbide dimethyl ether (dimethylisosorbid).Especially preferably use C 12-15The mixture of-alkyl benzoate and 2-ethyl-hexyl isostearate, C 12-15The mixture of-alkyl benzoate and the different pelargonate of isotridecyl, and C 12-15The mixture of-alkyl benzoate, 2-ethylhexyl isostearate and the different pelargonate of isotridecyl.
The oil phase of preparation of the present invention also contains for example wax of beeswax, Chinese wax (chinawax), rheum officinale beeswax and other insect of natural phant or animal wax, and shea butter and theobroma oil.
Can sneak into wetting Agent for Printing Inks in the present composition, to keep hydration or to make skin rehydration.By being provided, protective layer prevents that sealing is called softener from the moistening agent of skin evaporation.Additional softener provides softening or the skin moisten effect to skin surface, and to be considered to usually topical application be safe.Preferred softener comprises mineral oil, lanolin, vaseline, capric acid (capric) triglycerin aldehyde, sad triglycerin aldehyde, cholesterol; Siloxanes, for example polydimethylsiloxane, cyclomethicone; Prunus amygdalus oil, Jojoba oil, Lipoval A, Viscotrol C, sesame oil, wunflower seed oil, Oleum Cocois and wine stone oil, theobroma oil, sweet oil, Aloe extract (aloe extracts); Lipid acid, for example oleic acid and stearic acid; Fatty Alcohol(C12-C14 and C12-C18), for example hexadecanol and hexadecyl alcohol; Hexanodioic acid diisopropyl ester, hydroxybenzoate, C 9-15The different nonyl ester of benzoic ether, different n-nonanoic acid of-alcohol; Ether, for example polyoxypropylene butyl ether and polyoxypropylene cetyl ether, C 12-15-alkyl benzoate, and composition thereof.Most preferred softener is hydroxybenzoate, Aloe vulgaris (aloe vera), C 12-15-alkyl benzoate, and composition thereof.Softener can exist with the amount of about 1wt%~about 20wt% of total composition.The amount of softener is preferably about 2wt%~about 15wt%, most preferably from about 4wt%~about 10wt%.
With the water bonded, therefore, the moistening agent that holds it in skin surface is called wetting Agent for Printing Inks.The suitable wetting Agent for Printing Inks that can join in the present composition is, for example glycerine, polypropylene glycol, polyoxyethylene glycol, lactic acid, pyrrolidone carboxylic acid (pyrrolidon carboxylic acid), urea, phosphatide (phopholipids), collagen protein, elastin, ceramide, Yelkin TTS Sorbitol Powder, PEG-4, and composition thereof.The polymkeric substance moistening agent that other suitable moistening agent is a lower class: water-soluble and/or swellable and/or with the polysaccharide of water-setting gel, the polysaccharide of hyaluronic acid, chitosan and/or rich Fucose for example, it is for example conduct
Figure S05804920X20060818D000241
1000 (CAS-Nr.178463-23.5) obtain from SOLABIA S.Randomly with about 0.5wt%~about 8wt% of the present composition, the amount of preferably about 1wt%~about 5wt% exists one or more wetting Agent for Printing Inkss.
The water of the present composition can contain common cosmetics additive, for example pure, especially lower alcohol, preferred alcohol and/or Virahol, lower glycol or polyvalent alcohol and ether thereof, preferred propylene glycol, glycerol, ethylene glycol, ethylene glycol monomethyl ether or single-butyl ether, propylene glycol monomethyl ether or single ethyl ether or single-butyl ether, glycol ether monomethyl ether or single-butyl ether, propylene glycol monomethyl ether or single ethyl ether or single-butyl ether, glycol ether monomethyl ether or single ethyl ether and analogous products, polymkeric substance, suds-stabilizing agent; Ionogen and one or more thickening materials especially.The thickening material that can be used in the preparation of the present invention, helps to produce suitable product denseness comprises acrylate copolymer (carbomer), silicon-dioxide, magnesium and/or aluminosilicate, beeswax, stearic acid, Stearyl alcohol polysaccharide and derivative thereof, for example xanthan gum, hydroxypropylcellulose, polyacrylamide, acrylate cross linked polymkeric substance, preferred acrylate copolymer, 980,981,1382,2984,5984 for example independent type carbopole
Figure S05804920X20060818D000242
Or its mixture.Can be included in the present composition with in and the suitable neutralizing agent of component (for example emulsifying agent or frothing aid (foambuilder)/stablizer) include but not limited to hydroxide bases (alkali hydroxide), for example sodium hydroxide and potassium; Organic bases, for example diethanolamine (DEA), trolamine (TEA), amino methyl propyl alcohol and composition thereof; Amino acid is arginine and Methionin for example, and any aforesaid combination.The amount of neutralizing agent can be about 0.01wt%~about 8wt% of the present composition, preferred 1wt%~about 5wt%.
Adding the ionogen in the present composition, perhaps is that the behavior of change hydrophobic emulsifying agent is necessary.Therefore, the emulsion/microemulsion among the present invention can preferably contain a kind of ionogen of or several salt, comprising negatively charged ion such as chlorion, sulfate radical, carbonate, borate and aluminate, but is not limited to these.Other suitable ionogen can organic anion be the basis, such as, but be not limited to, lactic acid salt, acetate, benzoate, propionic salt, tartrate and Citrate trianion.Positively charged ion is preferably selected ammonium, alkylammonium, basic metal or alkaline-earth metal, magnesium ion, iron ion or zine ion.Particularly preferred salt is Repone K and sodium-chlor, sal epsom, zinc sulfate and composition thereof.In the present composition, the amount that ionogen can exist is that about 0.01% (weight) is to about 8% (weight).
Cosmetic composition of the present invention can be used as and is used to prevent people's epidermis or the composition that hair is subjected to ultraviolet damage, as barrier compositions.Particularly, this composition can emulsion, the form of thickening emulsion, gel, cream, emulsion, ointment, powder or solid tubular rods (solid tube stick) provides, and can pack with aerosol form on demand, also can mousse, foaming agent or spray form provide.When make-up composition of the present invention was not subjected to ultraviolet radiation or is used as barrier compositions for the protection human epidermal, said composition can be taked to suspend or be scattered in the suspension in solvent or the fatty substance, the form of dispersion; Perhaps as the form (specifically, O/W or w/o type, O/W/O or W/O/W type) of selecting to take emulsion or microemulsion, for example cream or emulsion, vesicular dispersion; Take ointment, gel, pipe dress solid bar form or aerosol mouse form.Emulsion also can contain anionic, non-ionic type, cationic or amphoteric surfactant.
The compounds of this invention protection skin and hair are not subjected to the UV-A radiation hazradial bundle.These compounds can be replenished by other UV-A sun-screening agents in the organic phase, thereby produce higher sun-proof result.These compounds can easily be sneaked in the different make-up compositions, and these compounds demonstrate more long wavelength's protection than other known UV-sun-screening agents, and demonstrate more long wavelength's protection than other commercially available water miscible UV-A sun-screening agents especially, thereby be effective UV-A lightscreening agent, rather than UV-A/UV-B gap lightscreening agent (gapfilter), and protecting skin is not painted by visible light.In addition; the remarkable advantage of new compound is shown in the general formula (I); these compounds present higher dullness than known other water-soluble UV-A sun-screening agents, and especially have than existing commercially available water-soluble UV-A sun-screening agent even better dullness, thereby produce better protection.Compound shown in the general formula (I) also presents excellent light stability.Be unexpectedly, the compound shown in the general formula (I) also makes emulsion-stabilizing, thereby can be used as the assistant for emulsifying agent of the present composition, if these compounds are taked emulsion form.Compound shown in the general formula (I) presents very low percutaneous permeation, and skin and hair are had good clinging power.
Provide the following example further to illustrate method and composition of the present invention.These embodiment only are exemplary, in no case are intended to limit protection scope of the present invention.
Embodiment 1
4-dicyano methylene radical-2,6-dimethyl-1,4-dihydropyridine-N-(oxyethyl group-oxyethyl group phosphoric acid ester one sodium salt):
Figure S05804920X20060818D000261
A) 4-dicyano methylene radical-2,6-dimethyl-1,4-dihydropyridine-N-(oxyethyl group-ethanol)
350ml three neck reaction flasks are equipped with thermometer, reflux exchanger and have the oil bath of magneton agitator, dress (is pressed Helv.Chim.Acta 1962 with the 4-dicyano methylene radical-4H-pyrans that is present in the 30.1g (175mmol) in the 150ml propyl carbinol in the flask, 1908-1917 prepares) and 20.2g (192mmol) 2-(2-amino ethoxy)-ethanol (Fluka), and under argon atmospher, heated 90 minutes.After the cooling, whole suspension are filtered, with ethyl acetate, Di Iso Propyl Ether and pentane washing filter residue, get the little tawny crystal of 20.3g after the drying successively.157~158 ℃ of fusing points, UV (THF) 360 and 372nm (32 ' 332).
B) 4-dicyano methylene radical-2,6-dimethyl-1,4-dihydropyridine-N-(oxyethyl group-oxyethyl group phosphoric acid ester one sodium salt)
750ml four neck reaction flasks are equipped with thermometer, dropping funnel, reflux exchanger, pH electrode and have the cooling bath of magneton agitator, under argon atmospher, dress is to be present in prepared 4-dicyano methylene radical-2 above the 19.5g (75mmol) among the 250mlTHF in the flask, 6-dimethyl-1,4-dihydropyridine-N-(oxyethyl group-ethanol) and 13.6ml (97.5mmol) triethylamine (Fluka) also are chilled to 10 ℃.Then, in 15 minutes, add the POCl that 13.8g (90mmol) is dissolved in 50mlTHF with dropping funnel 3Stirred the mixture under the room temperature 16 hours, and followed the tracks of reaction, filtering throw out, the NEt that is generated to remove with HPLC 3* HCl.Filtrate is chilled to 10 ℃ again, and adds the hexaoxacyclooctadecane-6-6 of 1mg, add the 2.0-n NaOH aqueous solution of 97.5ml then, check pH simultaneously.Restir reactant 90 minutes, and under 20 ℃, add the 2.0-n NaOH aqueous solution again, reach till 4 until pH.This moment, isolate water, and wash it with the 100ml ethyl acetate.Add the saturated NaCl aqueous solution of 50ml, so that the product precipitation, and it can be filtered out, again with the 200ml washing with acetone it.Get the 18.2g clear crystal after the drying.Solubleness 168g/l in the water.This salt of recrystallization in DMF.158~159 ℃ of fusing points; UV (water) 350nm (E=979).According to Berset et al., Internat.J. Cosmetic Science 18:167-177 (1996) is with 7: 3 water/glycerol mixture solution light stability of this salt of having made liquid phase measuring.Find that product has light stability.
Embodiment 2
4-dicyano methylene radical-2,6-dimethyl-1,4-dihydropyridine-N-(oxyethyl group sulfuric ester one sodium salt):
Figure S05804920X20060818D000271
A) 4-dicyano methylene radical-2,6-dimethyl-1,4-dihydropyridine-N-second-2-alcohol
350ml three neck reaction flasks are equipped with thermometer, reflux exchanger and have the oil bath of magneton agitator, dress (is pressed Helv.Chim.Acta 1962 with 25.8g (150mmol) the 4-dicyano methylene radical-4H-pyrans that is present in the 100ml thanomin (Fluka) in the flask, the 1908-1917 preparation), and under argon atmospher, be heated to 80 ℃, kept 30 minutes.Soon just observe thermopositive reaction after the reaction beginning.After the cooling,, and give filtration with 100ml propyl carbinol diluted mixture thing.Use 2 * 10ml cold water and 2 * 100ml washing with acetone filter residue successively.Get the little yellow crystals of 17.5g after the drying.267~268 ℃ of fusing points, UV (THF) 360 and 372nm (26 ' 305).
B) 4-dicyano methylene radical-2,6-dimethyl-1,4-dihydropyridine-N-(oxyethyl group sulfuric ester one sodium salt)
The 100ml reaction flask is equipped with agitator, reflux exchanger, thermometer, oil bath and argon atmospher, dress is to be present in the above-mentioned 4-dicyano of 2.15g (10mmol) methylene radical-2 in 9: 1 acetonitrile/pyridine mixtures of 30ml in the flask, 6-dimethyl-1, the 4-dihydropyridine-pure and mild 1.91g of N-second-2-(12mmol) sulphur trioxide-pyridine recombiner (Fluka).Violent stirring limit, limit keeps this mixture heating up to 60 ℃ 30 minutes.After 10 minutes, just in fact detect less than starting raw material with HPLC.Under the room temperature,, and filter it with this mixture of 30ml acetone diluted.With acetone, diisopropyl ether and pentane washing filter residue, get 3.1g clear crystal, 209~210 ℃ of fusing points after the drying.This material is dissolved in the 30ml water.Add the 1 normal 1-n NaOH aqueous solution, and stirred the mixture 15 minutes, and in rotary evaporator (rotavap), carry out high vacuum and concentrate.In filter residue, add 50ml water again, and as above concentrate.Repeat this process again 2 times, smell flavor until can't smell pyridine.Again dry substance is dissolved in 5 times in the water of its weight, adds 200mlTHF and make it precipitation, filter and with THF and washing with acetone residue, must the 2.9g clear crystal.198 ℃ of fusing points (decomposition); UV (water) 352nm (E=1261).Solubleness 〉=25g/l in the water.According to Berset et al., Internat.J.CosmeticScience18:167-177 (1996) is with 7: 3 water/glycerol mixture solution light stability of this product of having made liquid phase measuring.Find that this product has light stability.
Embodiment 3
4-dicyano methylene radical-2,6-dimethyl-1,4-dihydropyridine-N-[3-(N, N-dimethyl)-N-(oxyethyl group-ethoxy ethanol-yl)-propyl group-ammonium iodide]
A) 4-dicyano methylene radical-2,6-dimethyl-1,4-dihydropyridine-N-(3-[N, N-dimethylamino]-propane)
250ml three neck reaction flasks are equipped with thermometer, reflux exchanger and have the oil bath of magneton agitator, dress (is pressed Helv.Chim.Acta1962 with 14.5g (82.2mmol) the 4-dicyano methylene radical-4H-pyrans that is present in the 145ml propyl carbinol in the flask, 1908-1917 prepares) and 10.1g (99mmol) 3-(N, the N-dimethylamino)-propylamine (Fluka), and under argon atmospher, heated 2 hours.After the cooling, filtering suspension liquid with cold propyl carbinol washing filter residue, gets the little yellow crystals of 10.4g after the drying.187~188 ℃ of fusing points.UV (ethanol) 360nm (37 ' 287).
B) 2-[2-(2-iodo oxyethyl group)-oxyethyl group]-ethanol
The 25ml reaction flask is equipped with reflux exchanger, oil bath and magneton agitator, and dress is to be present in 2g (11.9mmol) 2-[2-(2-chloro the oxyethyl group)-oxyethyl group in the 20ml acetone in the flask]-ethanol (Fluka), 4g sodium iodide and 3g sodium bicarbonate.Reaction mixture refluxed is spent the night, filtered after cold.Filtrate is concentrated rotary evaporator, is dissolved in 5ml CH 2Cl 2After give filtration again.Then, concentrated filtrate in rotary evaporator gets the 2.5g yellow oil again.NMR confirms pure material (CDCl 3) 2.58 s wide (1H/OH); 3.22 t (2H/CH 2-J); 3.53-3.77m (10H/CH 2-O).
C) 4-dicyano methylene radical-2,6-dimethyl-1,4-dihydropyridine-N-[3-(N, N-dimethyl)-N-(oxyethyl group-ethoxy ethanol-yl)-propyl group-ammonium iodide]
The 50ml reaction flask is equipped with reflux exchanger, oil bath and magneton agitator, dress is to be present in the as above made 4-dicyano of 1.28g (5mmol) methylene radical-2 among the 15mlDMF in the flask, 6-dimethyl-1,4-dihydropyridine-N-(3-[N, N-dimethylamino]-propane), the above-mentioned 2-[2-of 1.34g (5.5mmol) (2-iodo oxyethyl group)-oxyethyl group]-ethanol.Reaction mixture refluxed is spent the night, and show no starting raw material with TLC.Concentrated reaction mixture in rotary evaporator carries out high vacuum (HV) drying subsequently.With hexanaphthene wash residual thing, wash it with ethyl acetate again, then recrystallization in ethanol.Get the 2.09g brown crystal.130~180 ℃ of fusing points (decomposition); UV (ethanol) 362nm (37 ' 946).
Embodiment 4
1-{2-[2-(4-dicyano methylene radical-2,6-dimethyl-4H-pyridine-1-yl)-oxyethyl group]-ethyl }-pyridine-N-oxide
A) 2-{1-[2-(2-chloro-oxyethyl group)-ethyl]-2, the inferior pyridin-4-yl of 6-dimethyl-1 H-}-propane dinitrile
750ml four neck reaction flasks are equipped with thermometer, dropping funnel, reflux exchanger, have the cooling heating bath of magneton agitator, under argon atmospher, dress is to be present in prepared 4-dicyano methylene radical-2 above the 19.5g (75mmol) among the 50ml THF in the flask, 6-dimethyl-1,4-dihydropyridine-N-(oxyethyl group-ethanol) (embodiment 6.1.a) and trace of triethylamine (Fluka) also are chilled to 10 ℃.Then, in 15 minutes, add the SOCl that 10.7g (90mmol) is dissolved in 50ml THF with dropping funnel 2Solution.Stirred the mixture under the room temperature 1 hour, reflux is 4 hours then.Follow the tracks of reaction with HPLC.Mixture is inclined on ice, is leached product, and in ethyl acetate recrystallization.Get white crystal, 148~149 ℃ of fusing points.
B) 1-{2-[2-(4-dicyano methylene radical-2,6-dimethyl-4H-pyridine-1-yl)-oxyethyl group]-second
Figure S05804920X20060818D000301
A) 2-[1-(3-hydroxyl-phenyl)-2, the inferior pyridin-4-yl of 6-dimethyl-1H-}-propane dinitrile
The 10ml reaction flask is equipped with reflux exchanger, magneton agitator and oil bath, under argon atmospher, 0.86g (5mmol) 4-dicyano methylene radical-4H-pyrans pack in the flask into (according to Helv.Chim.Acta1962,1908-1917 prepares) and 2.8g (25mmol) 3-amino-phenol (Fluka), and be heated to 140 ℃, kept 5 hours.While hot reaction mixture is poured among the 2n HCl of 100ml, and with twice of 100ml ethyl acetate extraction.Organic phase merges the back with 2n HCl back scrubbing, is concentrated in rotary evaporator and drying.The gained crystal washs with warm ethyl acetate and MeOH, and after drying, gets the 460mg white crystal.Fusing point〉300 ℃, TLC (EtOAc on the silica gel: Rf=0.15 hexane=1: 1).
B) 3-[3-(4-dicyano methylene radical-2,6-dimethyl-4H-pyridine-1-yl)-phenoxy group] propane-1-sulfonic acid
50ml three neck reaction flasks are equipped with thermometer, reflux exchanger, magneton agitator and add hot radical }-pyridinium chloride
The 50ml reaction flask is equipped with reflux exchanger, heating bath and magneton agitator, under argon atmospher, dress is to be present in the above-mentioned 2-{1-[2-of 1.4g (5mmol) (2-chloro-the oxyethyl group)-ethyl in the 25ml pyridine in the flask]-2, the inferior pyridin-4-yl of 6-dimethyl-lH-}-propane dinitrile, reflux 5 hours.Generate thick suspension, it is leached, and, wash with THF again with a small amount of cold pyridine washing.After the drying, get the 1.69g microlite, 248~251 ℃ of fusing points (decomposition), UV (water) 352nm (E=1149).Solubleness in the water〉〉 200g/l.
Embodiment 5
3-[3-(4-dicyano methylene radical-2,6-dimethyl-4H-pyridine-1-yl)-and phenoxy group] propane-1-sulfonic acid bath, under argon atmospher, dress is to be suspended in the above-mentioned 2-[1-of 263mg (1mmol) (3-hydroxyl-phenyl)-2 in anhydrous THF of 20ml and the 0.1ml dry DMF mixture, the inferior pyridin-4-yl of 6-dimethyl-1H-in the flask]-propane dinitrile and 26.5mg (1.05mmol) anhydrous Na H (95%).Observing hydrogen produces.After 45 minutes, with 1 of 134mg (1.1mmol), 3-N-morpholinopropanesulfonic acid lactone (propan sultone) adds in the suspension, and reaction mixture is heated to 70 ℃, keeps 5 hours, follows the tracks of with HPLC.Take advantage of cold filtering mixt, residue washs with a small amount of THF, gets the 260mg white powder.At MeOH/CH 2Cl 2Middle recrystallization is used CH 2Cl 2Washing crystal also gives drying, gets the 190mg clear crystal, 200 ℃ of fusing points (decomposition).UV (water) 352nm (E=1150), solubleness in the water〉50g/l.
Embodiment 6
The preparation of O/W type ultra light sun block lotion UV-B and UV-A
The wide spectrum ultra light sun block lotion that contains 2% embodiment, 1 made compound
Figure S05804920X20060818D000311
The A part is heated to 85 ℃ in reactor.The B part slowly added in 10 minutes, then added KOH, with the emulsion cooling and the degassing.
Embodiment 7
The sun-proof emulsion of water-resisting type
Figure S05804920X20060818D000322
Embodiment 8
The spray-type ultra light sun block lotion
Composition The INCI nomenclature % (weight)
A) PARSOL MCX Ethylhexyl methoxy cinnamate 1) 6.00
PARSOL 5000 4 methyl benzylidene camphor 1) 2.00
Emulgade SE-PE Stearin, 16/Stearyl alcohol polyoxyethylene (20) ether, 16/Stearyl alcohol polyoxyethylene (12) ether, 16/Stearyl alcohol, palmitinic acid hexadecyl ester mixture 2) 7.00
Eumulgin B-2 16/octodecyl alcohol polyoxyethylene (20) ether 2) 6.00
MVritol 318 (caprylic/capric) triglyceride level 2) 3.00
Cetiol A Lauric acid hexyl ester 2) 6.00
Silicone DC 345 fluids Cyclomethicone 6) 7.00
Antaron V-220 PVP/ eicosylene multipolymer 7) 2.00
Edeta BD The EDTA disodium salt 3) 0.10
Yoshinox BHT BHT 5) 0.05
Phenonip Phenoxyethyl alcohol, methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate, propylparaben and butyl p-hydroxybenzoate 8) 0.60
B) Deionized water Water q.s.100
Composition The INCI nomenclature % (weight)
Glycerine Glycerine 5) 5.00
C) PARSOL HS Phenylbenzimidazolesulfonic acid 1) 2.00
The product of embodiment 2 2.00
Deionized water Water 20.00
KOH 10%sol. Potassium hydroxide 4.40
Operation steps:
While stirring with A) partly be heated to 85 ℃.After stirring, stir and add B down) partly (80 ℃).Then, stir and add C down) partly (40 ℃) (guarantee that Parsol HS dissolves fully, if residual trace then adds small amount of alkali to be neutralized, until solution clarification, pH〉7).At last, pH regulator to being at least 7, and is chilled to room temperature.
The supplier:
1)DSM Nutritional Products,CH-4002 Basel/Switzerland
2)COGNIS,D-40551 Düsseldorf/Germany
3)BASF AG, D-67056 Ludwigshafen/Germany
4)GOODRICH COMPANY,Cleveland-OH 44141-3247/USA
5)FLUKA CHEMIE AG,CH-9471 Buchs/Switzerland
6)DOW CORNING CORP.,Midland-Mi 48686-0994/USA
7)ISP TECHNOLOGIES INC.,Wayne-NJ 07470/USA
8)NIPA LABORATORIES LTD,Mid Glam.-CF38 2SN/England
Embodiment 9
O/W VITAMIN type wide spectrum ultra light sun block lotion
Composition The INCI nomenclature % (weight)
A) PARSOL MCX 2-Ethylhexyl cinnamate 1) 4.00
PARSOL 1789 Butyl methoxyl group dibenzoyl methane 1) 1.00
PARSOL 5000 4 methyl benzylidene camphor 1) 3.50
Estol GMM 3650 Myristin 8) 4.00
Composition The INCI nomenclature % (weight)
Cetyl alcohol Cetyl alcohol 2.00
Ganex V-220 PVP/ eicosylene multipolymer 4) 2.00
Tegosoft TN Phenylformic acid C 12-15Alkyl ester 5) 10.00
Myritol 318 (caprylic/capric) triglyceride level 6) 6.00
Yoshinox BHT BHT 0.05
Edeta BD The EDTA disodium 2) 0.10
Phenonip Phenoxyethyl alcohol, P-hydroxybenzoic acid first 3) 0.60
Ester, ethyl p-hydroxybenzoate, propylparaben and butyl p-hydroxybenzoate
AMPHISOL K Potassium cetyl phosphate 1) 2.00
VITAMIN EACETATE VITAMIN E ACETATE 1) 2.00
B) Deionized water Water ad 100
Propylene glycol Propylene glycol 5.00
Carbopol 981(1%sol.) Acrylate copolymer 7) 10.00
D-PANTHENOL75L Panthenol 1) 2.70
C) KOH(10%sol.) Potassium hydroxide 0.70
D) Deionized water Water 20.00
Ester, ethyl p-hydroxybenzoate, propylparaben and butyl p-hydroxybenzoate
The product of embodiment 2 2.00
PARSOL HS Phenylbenzimidazolesulfonic acid 1) 2.00
KOH 10%sol. Potassium hydroxide 4.40
Operation steps:
While stirring with A) partly be heated to 85 ℃.After stirring, stir the B that is added on 75 ℃ of preheatings down) part and C) partly to 75 ℃.Add and be preheating to 75 ℃ D) partly (guarantee that Parsol HS dissolves fully) if residual trace then adds small amount of alkali and neutralized, until the solution clarification.Homogenized 30 seconds with 11000 rev/mins speed.Be chilled to room temperature.
Physical data:
pH:7.20
Viscosity (Brookfield RVT, 25 ℃, 6,10 rev/mins of rotors): about 12350cP
SPF: in vivo test 5 tested objects, LaboratoireDermscan, Lyon Ref.98098 (02.98) by the Colipa agreement
The supplier:
9)ROCHE VITAMINS LTD,CH-4070 Basel/Switzerland
10)BASF AG,D-67056 Ludwigshafen/Germany
11) NIPA LABORATORIES LTD,Mid Glam.-CF38 2SN/England
12)ISP TECHNOLOGIES INC.,Wayne-NJ 07470/USA
13)GOLDSCHMIDT AG,D-45127/Germany
14)COGNIS,D-40551Düsseldorf/Germany
15) B.F.GOODRICH COMPANY;Cleveland-OH44141/USA
16) UNICHEMA CHEMIE GmbH,D-46446 Emmerich/Germany

Claims (22)

1. the compound shown in the general formula I
Figure FA20191743200580004920X01C00011
In the formula,
R 1And R 2For-CN;
R 3, R 4, R 5And R 6Be independently selected from hydrogen atom or C 1-C 10Alkyl,
X is for containing 1 to 20 carbon atom and optional 1 to 10 heteroatoms, and contains the alkyl of the group of at least one lotus positive electricity or bear electricity, and
Y is counter ion.
2. the described compound of claim 1, wherein X is for containing 1 to 20 carbon atom and optional 1 to 10 heteroatoms, and contains alkyl, alkaryl or the alkyl-cycloalkyl of the group of at least one lotus positive electricity or negative charge.
3. the described compound of claim 2, wherein X is C 1-C 10Alkylidene group, the optional group that contains 1 to 10 heteroatoms and comprise at least one lotus positive electricity or negative charge of this alkylidene group.
4. any one described compound in the claim 1 to 3, wherein X contains 1 to 6 heteroatoms.
5. the described compound of claim 4, wherein heteroatoms is selected from nitrogen-atoms, Sauerstoffatom, sulphur atom and phosphorus atom.
6. any one described compound in the claim 1 to 5, wherein positive charge of the group band of lotus positive electricity or bear electricity.
7. the described compound of claim 6, wherein the group of lotus positive electricity or bear electricity is a quaternary ammonium group.
8. the described compound of claim 7, wherein Y is a halide-ions.
9. any one described compound in the claim 1 to 5, wherein negative charge of the group band of lotus positive electricity or bear electricity.
10. the described compound of claim 9, wherein the group with a negative charge is selected from-COO -,-O-SO 3 -With-O-PO 3H -
11. the described compound of claim 10, wherein Y is alkalimetal ion, alkaline-earth metal ions, triethanol ammonium ion, amino methyl propyl alcohol ion or trometamol ion.
12. any one described compound, wherein R in the claim 1 to 11 3And R 4The group hydrogen atom of respectively doing for oneself.
13. any one described compound, wherein R in the claim 1 to 12 5And R 6Group is independently selected from hydrogen atom and C 1-C 6Alkyl.
14. any one described compound, wherein R in the claim 1 to 13 1And R 2Group is cyano group.
15. the described compound of claim 1, promptly
16. contain the UV-A shading composition of any one compound that defines in the claim 1 to 15.
17. the described UV-A shading composition of claim 16, said composition are the make-up compositions that is used for protecting skin or the anti-UV-A irradiation of hair.
18. claim 16 or 17 described UV-A shading compositions, said composition comprises one or more additional sun-screening agents, and these sun-screening agents are selected from particulate pigment and polymer class UV screening agent.
19. the described UV-A shading composition of claim 18, particulate pigment are the particulate TiO of granularity 5nm to 200nm 2
20. the described UV-A shading composition of claim 18, wherein the polymer class UV screening agent is an organo-siloxane.
21. the described UV-A shading composition of claim 20, wherein organo-siloxane is the organo-siloxane that contains the phenylmalonate ester group.
22. in the claim 1 to 15 any one the purposes of the compound that defines in preparation UV-A sun-screening agent.
CN200580004920XA 2004-02-13 2005-02-11 Ionic UV-A sunscreens and compositions containing them Expired - Fee Related CN1918126B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04003294.8 2004-02-13
EP04003294 2004-02-13
PCT/EP2005/001379 WO2005080341A1 (en) 2004-02-13 2005-02-11 Ionic uv-a sunscreens and compositions containing them

Publications (2)

Publication Number Publication Date
CN1918126A CN1918126A (en) 2007-02-21
CN1918126B true CN1918126B (en) 2010-07-21

Family

ID=34878157

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200580004920XA Expired - Fee Related CN1918126B (en) 2004-02-13 2005-02-11 Ionic UV-A sunscreens and compositions containing them

Country Status (9)

Country Link
US (1) US7897779B2 (en)
EP (1) EP1716117B1 (en)
JP (1) JP5341316B2 (en)
KR (1) KR101182959B1 (en)
CN (1) CN1918126B (en)
AT (1) ATE508116T1 (en)
AU (1) AU2005215881B2 (en)
DE (1) DE602005027811D1 (en)
WO (1) WO2005080341A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2416351A (en) 2004-06-29 2006-01-25 Ciba Sc Holding Ag Use of myocyanine derivatives for the protection of human hair and skin from UV radiation
AU2006274968B2 (en) 2005-07-29 2012-02-23 Basf Se Stabilization of body-care and household products against degradation by UV radiation using merocyanine derivatives
WO2007017179A1 (en) * 2005-08-05 2007-02-15 Dsm Ip Assets B.V. Use of ionic uv-a sunscreens
CN101268039A (en) 2005-09-20 2008-09-17 帝斯曼知识产权资产管理有限公司 Novel carboxylic acid derivatives
CN101426481B (en) 2006-04-21 2012-12-05 帝斯曼知识产权资产管理有限公司 Use of opioid receptor antagonists
WO2007144189A2 (en) 2006-06-16 2007-12-21 Dsm Ip Assets B.V. Compositions based on hyperbranched condensation polymers and novel hyperbranched condensation polymers
EP2049134A2 (en) 2006-07-14 2009-04-22 DSMIP Assets B.V. Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders
DE102007024345A1 (en) * 2007-05-22 2008-11-27 Beiersdorf Ag Cosmetic preparation, useful e.g. as a sunscreen, comprises 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridin-N-(ethyloxysulfate ester salt), 4-(tert.-butyl)-4'-methoxydibenzoylmethane and 2-ethylhexyl-2-cyano-3,3-diphenylacrylate
DE102007024347A1 (en) * 2007-05-22 2008-11-27 Beiersdorf Ag Cosmetic formulation for protecting skin aging, particularly UV-induced skin aging, and for use as sun protective agents, comprises dihydropyridine ethyloxysulfate ester salt and ethylhexyloxyphenol methoxyphenyl triazine
DE102007024346A1 (en) * 2007-05-22 2008-11-27 Beiersdorf Ag Cosmetic formulation for protecting skin aging, particularly UV-induced skin aging, and for use in cosmetic sprays as sun protective agents, comprises dihydropyridine ethyloxysulfate ester salt and hydoxybenzoyl benzoic acid hexyl ester
DE102007024348A1 (en) * 2007-05-22 2008-11-27 Beiersdorf Ag Cosmetic formulation for use in cosmetic sprays, particularly in sun protective agents, comprises dicyanomethylene-dimethyl-dihydropyridine-(ethyloxysulfate ester mono sodium salt), tris (biphenyl)-triazine, UV filters and diols
WO2008155073A2 (en) 2007-06-19 2008-12-24 Cognis Ip Management Gmbh Shampoo composition having improved care properties
EP2070525A1 (en) 2007-12-11 2009-06-17 DSM IP Assets B.V. Compositions comprising Magnolol and/or Honokiol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
EP2070524A1 (en) 2007-12-11 2009-06-17 DSM IP Assets B.V. Compositions comprising Magnolol and/or Honokiol and glucosamine and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
EP2398478A1 (en) 2009-02-23 2011-12-28 DSM IP Assets B.V. Cajanus extracts and glucosamine for inflammatory disorders
WO2011070071A2 (en) 2009-12-09 2011-06-16 Dsm Ip Assets B.V. Novel compound
EP2509575B1 (en) 2009-12-09 2014-08-27 DSM IP Assets B.V. Novel compounds
CN102656208A (en) 2009-12-09 2012-09-05 帝斯曼知识产权资产管理有限公司 UV absorbing dentritic polyether prepared by polymerization of oxetanes
US8735632B2 (en) 2009-12-09 2014-05-27 Dsm Ip Assets B.V. Compounds
US20120282201A1 (en) 2009-12-09 2012-11-08 Alexander Schlifke-Poschalko Novel compounds
EP2509576B1 (en) 2009-12-09 2014-08-27 DSM IP Assets B.V. Polyglycerol based UV filter comprising p-dimethylamino benzoate
WO2011070077A2 (en) 2009-12-09 2011-06-16 Dsm Ip Assets B.V. Novel compound
EP2523943B1 (en) 2010-01-15 2014-11-19 DSM IP Assets B.V. Process to make uv radiation absorbing 2-phenyl-1,2,3-benzotriazoles
WO2011121093A1 (en) 2010-03-31 2011-10-06 Dsm Ip Assets B.V. Use of organic compounds in hair care
US9445979B2 (en) 2010-04-12 2016-09-20 Dsm Ip Assets B.V. Hair treatment composition containing gambogic acid, ester or amide
WO2012010624A2 (en) 2010-07-23 2012-01-26 Dsm Ip Assets B.V. Topical use of steviol or derivatives in hair care
US20140044656A1 (en) 2011-03-01 2014-02-13 Dsm Ip Assets B.V. Novel use
EP2522328A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and ascorbyl-2-glucoside
EP2522335A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and sodium-ascorbyl-phophate
EP2522329A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and arbutin
EP2522332A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and magnesium-ascorbyl-phosphate
EP2522331A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and niacinamide
EP2522330A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and an edelweiss extract
WO2013041515A1 (en) 2011-09-20 2013-03-28 Dsm Ip Assets B.V. Novel polyester based uv filters
KR102003093B1 (en) 2012-01-09 2019-07-23 디에스엠 아이피 어셋츠 비.브이. Use of danielone and derivatives thereof in skin care
EP2623094A1 (en) 2012-02-02 2013-08-07 DSM IP Assets B.V. Use of an edelweiss extract
EP3052202B1 (en) 2013-10-04 2019-03-06 DSM IP Assets B.V. Skin tanning extract
EP2873440A1 (en) 2013-11-19 2015-05-20 DSM IP Assets B.V. Use of an edelweiss extract in hair care for stimulating hair growth
EP2873414A1 (en) 2013-11-19 2015-05-20 DSM IP Assets B.V. Use of an edelweiss extract in hair care for the prevention of hair graying
KR102487937B1 (en) 2014-10-17 2023-01-13 디에스엠 아이피 어셋츠 비.브이. Use of a cosmetic composition comprising 10-hydroxystearic acid
CN107207691B (en) 2014-12-04 2020-11-10 路博润先进材料公司 Viscosity modification of compositions containing organic phases
EP3709956A1 (en) 2017-11-13 2020-09-23 DSM IP Assets B.V. Cosmetic or dermatological compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321130A (en) * 1992-02-10 1994-06-14 Molecular Probes, Inc. Unsymmetrical cyanine dyes with a cationic side chain
WO1995001341A1 (en) * 1993-06-30 1995-01-12 Abbott Laboratories Intercalators having affinity for dna and methods of use
EP1362894A2 (en) * 2002-02-14 2003-11-19 Fuji Photo Film Co., Ltd. Method for optical measurement of multi-stranded nucleic acid using cyanine dyes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU84264A1 (en) * 1982-07-08 1984-03-22 Oreal NOVEL SULFONAMIDES DERIVED FROM 3-BENZYLIDENE CAMPHOR AND THEIR APPLICATION AS U.V. FILTERS, ESPECIALLY IN COSMETIC COMPOSITIONS
ES2157268T5 (en) * 1994-02-24 2004-12-01 SYMRISE GMBH & CO KG COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING PHENYLENE-1,4-BISBENCIMIDAZOLSULFONIC ACIDS.
US5734058A (en) * 1995-11-09 1998-03-31 Biometric Imaging, Inc. Fluorescent DNA-Intercalating cyanine dyes including a positively charged benzothiazole substituent
US5783114A (en) * 1996-12-02 1998-07-21 International Business Machines Corporation Liquid crystalline display
DE60307234T2 (en) 2002-02-12 2007-07-05 Dsm Ip Assets B.V. SUNSCREEN COMPOSITIONS AND DIHYDROPYRIDINE AND DIHYDROPYRANEES

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321130A (en) * 1992-02-10 1994-06-14 Molecular Probes, Inc. Unsymmetrical cyanine dyes with a cationic side chain
WO1995001341A1 (en) * 1993-06-30 1995-01-12 Abbott Laboratories Intercalators having affinity for dna and methods of use
EP1362894A2 (en) * 2002-02-14 2003-11-19 Fuji Photo Film Co., Ltd. Method for optical measurement of multi-stranded nucleic acid using cyanine dyes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Gen-etsu Matsubayashi et al..Preparation and Properties of AzaTCNQ-Anion Salts and Mixed AzaTCNQ-/TCNQ-/TCNQ Salts of some Tetrakis(isocyanide)rhodium(I)Cation,and X-Ray Crystal Structure of the AzaTCNQ-Tetrakis(2,6-dimethylphenylisocyanide)rhodium(I)+Salt.Inorganica Chimica Acta63.1982,63217-224. *
H.Urayama et al..New Organic Conductors Based on AzaTCNQ.Synthetic Metals19.1987,19469-474. *

Also Published As

Publication number Publication date
US7897779B2 (en) 2011-03-01
EP1716117B1 (en) 2011-05-04
US20070275090A1 (en) 2007-11-29
ATE508116T1 (en) 2011-05-15
JP5341316B2 (en) 2013-11-13
WO2005080341A1 (en) 2005-09-01
EP1716117A1 (en) 2006-11-02
DE602005027811D1 (en) 2011-06-16
KR20060123540A (en) 2006-12-01
AU2005215881A1 (en) 2005-09-01
JP2007523078A (en) 2007-08-16
AU2005215881B2 (en) 2010-11-11
KR101182959B1 (en) 2012-09-18
CN1918126A (en) 2007-02-21

Similar Documents

Publication Publication Date Title
CN1918126B (en) Ionic UV-A sunscreens and compositions containing them
JP4510466B2 (en) Sunscreen compositions and dihydropyridines and dihydropyrans
CN101052659B (en) Additive for uv-sunscreen preparations
AU2005226922B2 (en) UV absorbing chromophores covalently bonded to hyperbranched polymers
EP1991604A1 (en) Novel heterocyclic substituted condensation polymers
WO2007017179A1 (en) Use of ionic uv-a sunscreens
PL182416B1 (en) Novel solar filters, photoprotective cosmetic compositions containing them and their applications
CN100424076C (en) Organosilicone derivatives of amino hydroxybenzophenones and their use as UV-A filters in cosmetic preparations
EP1521798B1 (en) Sunscreens
EP1515694A1 (en) Benzoxazole and benzodiazole uv-a sunscreens

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100721

Termination date: 20150211

EXPY Termination of patent right or utility model